Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-22

Clinical Trial Update: A Trial of 2 Disease-Modifying Drugs (Metformin and N-acetylcysteine ) to Promote TB Lung Function Recovery [Phase 3]

View source ↗

Summary

This document announces a Phase 3 clinical trial testing metformin and N-acetylcysteine to promote tuberculosis lung function recovery, which is currently not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • N-acetylcysteine (N-acetylcysteine)
  • metformin (metformin)

Snippet

Sponsor: Open Source Pharma Foundation | Conditions: Tuberculosis | Phase 3 | Status: NOT_YET_RECRUITING